Healthpeak Properties (NYSE:DOC) Raised to Outperform at BNP Paribas

Healthpeak Properties (NYSE:DOC) was upgraded by investment analysts at BNP Paribas from a “neutral” rating to an “outperform” rating in a research report issued to clients and investors on Friday, Marketbeat.com reports. The firm currently has a $21.00 target price on the real estate investment trust’s stock, up from their previous target price of $19.00. BNP Paribas’ price objective suggests a potential upside of 11.70% from the stock’s previous close.

A number of other brokerages also recently issued reports on DOC. Compass Point cut their target price on Healthpeak Properties from $19.00 to $18.00 and set a “buy” rating for the company in a research note on Tuesday, January 2nd. Royal Bank of Canada raised their price objective on Healthpeak Properties from $21.00 to $22.00 and gave the company an “outperform” rating in a research note on Wednesday, April 10th. KeyCorp reaffirmed a “sector weight” rating on shares of Healthpeak Properties in a research note on Friday, January 5th. Wells Fargo & Company assumed coverage on Healthpeak Properties in a research note on Monday, March 25th. They issued an “equal weight” rating and a $19.00 price objective for the company. Finally, Mizuho reaffirmed a “buy” rating and issued a $22.00 price objective on shares of Healthpeak Properties in a research note on Monday, April 22nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $18.36.

Healthpeak Properties Stock Performance

Shares of DOC stock opened at $18.80 on Friday. The company has a market cap of $13.34 billion, a price-to-earnings ratio of 53.72, a price-to-earnings-growth ratio of 1.81 and a beta of 1.02. The stock has a 50 day simple moving average of $16.66 and a 200-day simple moving average of $13.75. Healthpeak Properties has a 12-month low of $15.24 and a 12-month high of $22.38. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.00.

Hedge Funds Weigh In On Healthpeak Properties

Several hedge funds have recently bought and sold shares of DOC. Norges Bank purchased a new position in Healthpeak Properties during the fourth quarter worth $34,883,000. Leeward Investments LLC MA acquired a new stake in shares of Healthpeak Properties during the fourth quarter worth $13,038,000. abrdn plc boosted its holdings in shares of Healthpeak Properties by 1,749.1% during the fourth quarter. abrdn plc now owns 919,351 shares of the real estate investment trust’s stock worth $12,237,000 after purchasing an additional 869,631 shares during the last quarter. Angelo Gordon & CO. L.P. acquired a new stake in shares of Healthpeak Properties during the fourth quarter worth $3,713,000. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Healthpeak Properties by 6.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,943,465 shares of the real estate investment trust’s stock worth $52,488,000 after purchasing an additional 239,972 shares during the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.